Hangzhou Tigermed Consulting Co., Ltd.
SZSE:300347.SZ
62.3 (CNY) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Hangzhou Tigermed Consulting Co., Ltd. |
Symbool | 300347.SZ |
Munteenheid | CNY |
Prijs | 57.41 |
Beurswaarde | 47,125,745,634 |
Dividendpercentage | 0.97% |
52-weken bereik | 55.94 - 130 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Xiaoping Ye D.Phil, EMBA, M.D., Ph.D. |
Website | https://www.tigermed.net |
An error occurred while fetching data.
Over Hangzhou Tigermed Consulting Co., Ltd.
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)